These clinical findings indicate that low LSD1 expression levels lead to high expression of CD74, as well as more infiltration of effector CD8+ T cells, ultimately achieving a longer DoR in advanced HCC patients. The gene discussed is CD8A; the disease is hepatocellular carcinoma.